Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Publisher : public library of science Subject : covid-19 Subject : emotional engagement Subject : influenza, human
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2021 Dec 02; Vol. 17 (12), pp. e1010022. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection.

  • Authors : Khateeb D; Department of Immunology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Gabrieli T

Subjects: COVID-19*/COVID-19*/COVID-19*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2022 Jan 12; Vol. 18 (1), pp. e1010242. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.

Subjects: Vaccination*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: PLoS pathogens [PLoS Pathog] 2021 Dec 28; Vol. 17 (12), pp. e1010211. Date of Electronic Publication: 2021 Dec 28 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.

  • Authors : Gram MA; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.; Nielsen J

Subjects: SARS-CoV-2*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*immunology

  • Source: PLoS medicine [PLoS Med] 2021 Dec 17; Vol. 18 (12), pp. e1003874. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement.

Subjects: Trust*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: PloS one [PLoS One] 2021 Dec 09; Vol. 16 (12), pp. e0260216. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Can COVID-19 herd immunity be achieved at a city level?

  • Authors : Arbel Y; Sir Harry Solomon School of Economics and Management, Western Galilee College, Acre, Israel.; Arbel Y

Subjects: Immunity, Herd* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: PloS one [PLoS One] 2024 May 29; Vol. 19 (5), pp. e0299574. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.

  • Authors : Nour D; Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Science & Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.; Aix-Marseille Univ., Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/epidemiology COVID-19 breakthrough infections

  • Source: PloS one [PLoS One] 2024 May 09; Vol. 19 (5), pp. e0302579. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.

  • Authors : Azamar-Llamas D; Department of Gastroenterology and Liver Transplant Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Arenas-Martinez JS

Subjects: Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: PloS one [PLoS One] 2024 Mar 28; Vol. 19 (3), pp. e0301198. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters.

  • Authors : Diego JG; Infectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca-Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Animals SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Jan 10; Vol. 20 (1), pp. e1011805. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia.

  • Authors : Batmunkh B; School of Biomedicine, Mongolian National University of Medical Sciences, Sainshand, Mongolia.; Otgonbayar D

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult

  • Source: PloS one [PLoS One] 2023 Dec 08; Vol. 18 (12), pp. e0295167. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×